Literature DB >> 23325087

p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase.

Hiroshi Watanabe1, Yohei Miyamoto, Daisuke Honda, Hisae Tanaka, Qiong Wu, Masayuki Endo, Tsuyoshi Noguchi, Daisuke Kadowaki, Yu Ishima, Shunsuke Kotani, Makoto Nakajima, Keiichiro Kataoka, Shokei Kim-Mitsuyama, Motoko Tanaka, Masafumi Fukagawa, Masaki Otagiri, Toru Maruyama.   

Abstract

The accumulation of p-cresyl sulfate (PCS), a uremic toxin, is associated with the mortality rate of chronic kidney disease patients; however, the biological functions and the mechanism of its action remain largely unknown. Here we determine whether PCS enhances the production of reactive oxygen species (ROS) in renal tubular cells resulting in cytotoxicity. PCS exhibited pro-oxidant properties in human tubular epithelial cells by enhancing NADPH oxidase (nicotinamide adenine dinucleotide phosphate-oxidase) activity. PCS also upregulated mRNA levels of inflammatory cytokines and active TGF-β1 protein secretion associated with renal fibrosis. Knockdown of p22(phox) or Nox4 expression suppressed the effect of PCS, underlining the importance of NADPH oxidase activation on its mechanism of action. PCS also reduced cell viability by increasing ROS production. The toxicity of PCS was largely suppressed in the presence of probenecid, an organic acid transport inhibitor. Administration of PCS for 4 weeks caused significant renal tubular damage in 5/6-nephrectomized rats by enhancing oxidative stress. Thus, the renal toxicity of PCS is attributed to its intracellular accumulation, leading to both increased NADPH oxidase activity and ROS production, which, in turn, triggers induction of inflammatory cytokines involved in renal fibrosis. This mechanism is similar to that for the renal toxicity of indoxyl sulfate.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23325087     DOI: 10.1038/ki.2012.448

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  100 in total

1.  DNA hypermethylation of sFRP5 contributes to indoxyl sulfate-induced renal fibrosis.

Authors:  Yanlin Yu; Xu Guan; Ling Nie; Yong Liu; Ting He; Jiachuan Xiong; Xinli Xu; Yan Li; Ke Yang; Yiqin Wang; Yunjian Huang; Bing Feng; Jingbo Zhang; Jinghong Zhao
Journal:  J Mol Med (Berl)       Date:  2017-05-15       Impact factor: 4.599

2.  Effects of Probiotics on Inflammation and Uremic Toxins Among Patients on Dialysis: A Systematic Review and Meta-Analysis.

Authors:  Charat Thongprayoon; Wisit Kaewput; Spencer T Hatch; Tarun Bathini; Konika Sharma; Karn Wijarnpreecha; Patompong Ungprasert; Matthew D'Costa; Michael A Mao; Wisit Cheungpasitporn
Journal:  Dig Dis Sci       Date:  2018-08-11       Impact factor: 3.199

Review 3.  Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function.

Authors:  Ke Wang; Bryan Kestenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-28       Impact factor: 8.237

4.  A Renal Clinician's Guide to the Gut Microbiota.

Authors:  Matthew Snelson; Annabel Biruete; Catherine McFarlane; Katrina Campbell
Journal:  J Ren Nutr       Date:  2020-01-09       Impact factor: 3.655

Review 5.  Gut Microbiota in Cardiovascular Health and Disease.

Authors:  W H Wilson Tang; Takeshi Kitai; Stanley L Hazen
Journal:  Circ Res       Date:  2017-03-31       Impact factor: 17.367

6.  Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.

Authors:  Ruben Poesen; Pieter Evenepoel; Henriette de Loor; Dirk Kuypers; Patrick Augustijns; Björn Meijers
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-15       Impact factor: 8.237

Review 7.  The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.

Authors:  Raymond Vanholder; Eva Schepers; Anneleen Pletinck; Evi V Nagler; Griet Glorieux
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

Review 8.  The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective.

Authors:  Paula Mosińska; Martin Storr; Jakub Fichna
Journal:  Therap Adv Gastroenterol       Date:  2015-09       Impact factor: 4.409

Review 9.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Authors:  Ali Ramezani; Ziad A Massy; Björn Meijers; Pieter Evenepoel; Raymond Vanholder; Dominic S Raj
Journal:  Am J Kidney Dis       Date:  2015-11-15       Impact factor: 8.860

10.  Protein-bound uremic toxins induce tissue remodeling by targeting the EGF receptor.

Authors:  Chiao-Yin Sun; Guang-Huar Young; Yu-Ting Hsieh; Yau-Hung Chen; Mai-Szu Wu; Vin-Cent Wu; Jia-Hung Lee; Chin-Chan Lee
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.